Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
96.41 CHF | +1.01% | -39.82% | -47.70% |
15/07 | Moderna Insider Sold Shares Worth $1,756,177, According to a Recent SEC Filing | MT |
12/07 | China approves CSPC Pharma's RSV vaccine for clinical trials | RE |
- Stock Market
- Equities
- MRNA Stock
- 0QF Stock
- News Moderna, Inc.
- Other languages